Optogenetic control of nuclear protein export.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 26853913)

Published in Nat Commun on February 08, 2016

Authors

Dominik Niopek1,2,3, Pierre Wehler1, Julia Roensch1, Roland Eils1,2,3, Barbara Di Ventura2,3

Author Affiliations

1: Department of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
2: Department of Bioinformatics and Functional Genomics, Synthetic Biology Group, Institute for Pharmacy and Biotechnology (IPMB), University of Heidelberg, Im Neuenheimer Feld 364, 69120 Heidelberg, Germany.
3: Center for Quantitative Analysis of Molecular and Cellular Biosystems (BioQuant), University of Heidelberg, Im Neuenheimer Feld 267, 69120 Heidelberg, Germany.

Articles cited by this

Multiplex genome engineering using CRISPR/Cas systems. Science (2013) 55.53

RNA-guided human genome engineering via Cas9. Science (2013) 48.29

WAF1, a potential mediator of p53 tumor suppression. Cell (1993) 38.72

Regulation of p53 stability by Mdm2. Nature (1997) 18.20

Development and applications of CRISPR-Cas9 for genome engineering. Cell (2014) 13.50

A model for p53-induced apoptosis. Nature (1997) 11.38

Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector. Nat Biotechnol (2004) 10.60

Histone-GFP fusion protein enables sensitive analysis of chromosome dynamics in living mammalian cells. Curr Biol (1998) 8.12

Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region. Proc Natl Acad Sci U S A (1999) 6.81

Spatiotemporal control of cell signalling using a light-switchable protein interaction. Nature (2009) 6.74

Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. Exp Cell Res (1998) 6.11

A one pot, one step, precision cloning method with high throughput capability. PLoS One (2008) 5.94

Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA. Chem Biol (1997) 5.49

Krüppel-associated boxes are potent transcriptional repression domains. Proc Natl Acad Sci U S A (1994) 4.84

Rapid blue-light-mediated induction of protein interactions in living cells. Nat Methods (2010) 4.70

A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J (1999) 4.68

High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice. PLoS One (2011) 3.90

Cleavage of foot-and-mouth disease virus polyprotein is mediated by residues located within a 19 amino acid sequence. J Gen Virol (1991) 3.48

p53 dynamics control cell fate. Science (2012) 3.30

Interaction of MAP kinase with MAP kinase kinase: its possible role in the control of nucleocytoplasmic transport of MAP kinase. EMBO J (1997) 2.99

Nuclear-cytoplasmic shuttling of C-ABL tyrosine kinase. Proc Natl Acad Sci U S A (1998) 2.73

Comparative genomics, evolution and origins of the nuclear envelope and nuclear pore complex. Cell Cycle (2004) 2.65

A nuclear export signal in the N-terminal regulatory domain of IkappaBalpha controls cytoplasmic localization of inactive NF-kappaB/IkappaBalpha complexes. Proc Natl Acad Sci U S A (2000) 2.64

TULIPs: tunable, light-controlled interacting protein tags for cell biology. Nat Methods (2012) 2.59

Using optogenetics to interrogate the dynamic control of signal transmission by the Ras/Erk module. Cell (2013) 2.22

Optogenetic protein clustering and signaling activation in mammalian cells. Nat Methods (2013) 2.22

NESbase version 1.0: a database of nuclear export signals. Nucleic Acids Res (2003) 2.21

Positive-selection vectors using the F plasmid ccdB killer gene. Gene (1994) 2.12

Optical control of protein activity by fluorescent protein domains. Science (2012) 2.10

Nucleocytoplasmic shuttling of signal transducers. Nat Rev Mol Cell Biol (2004) 2.04

Identification of nuclear export inhibitors with potent anticancer activity in vivo. Cancer Res (2009) 2.00

Optogenetic control of organelle transport and positioning. Nature (2015) 1.99

Designing photoswitchable peptides using the AsLOV2 domain. Chem Biol (2012) 1.99

Nuclear export of actin: a novel mechanism regulating the subcellular localization of a major cytoskeletal protein. EMBO J (1998) 1.89

CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications. Leukemia (2013) 1.76

Evidence for a shared nuclear pore complex architecture that is conserved from the last common eukaryotic ancestor. Mol Cell Proteomics (2009) 1.74

An inhibitor of nuclear export activates the p53 response and induces the localization of HDM2 and p53 to U1A-positive nuclear bodies associated with the PODs. Exp Cell Res (1999) 1.74

Regulation of p53 localization. Eur J Biochem (2001) 1.57

Activation of p53 in cervical carcinoma cells by small molecules. Proc Natl Acad Sci U S A (2000) 1.52

The maximal size of protein to diffuse through the nuclear pore is larger than 60kDa. FEBS Lett (2007) 1.30

Photoactivatable CRISPR-Cas9 for optogenetic genome editing. Nat Biotechnol (2015) 1.28

A red/far-red light-responsive bi-stable toggle switch to control gene expression in mammalian cells. Nucleic Acids Res (2013) 1.22

Nuclear export inhibition through covalent conjugation and hydrolysis of Leptomycin B by CRM1. Proc Natl Acad Sci U S A (2013) 1.21

A light-inducible organelle-targeting system for dynamically activating and inactivating signaling in budding yeast. Mol Biol Cell (2013) 1.19

Ultraviolet-B-mediated induction of protein-protein interactions in mammalian cells. Nat Commun (2013) 1.17

Loss of IkappaB alpha-mediated control over nuclear import and DNA binding enables oncogenic activation of c-Rel. Mol Cell Biol (1998) 1.07

Engineering light-inducible nuclear localization signals for precise spatiotemporal control of protein dynamics in living cells. Nat Commun (2014) 1.07

Leptomycins A and B, new antifungal antibiotics. II. Structure elucidation. J Antibiot (Tokyo) (1983) 1.02

Ectopic expression of human p53 inhibits entry into S phase and induces apoptosis in the Drosophila eye imaginal disc. Oncogene (1999) 1.00

Benchmarking of optical dimerizer systems. ACS Synth Biol (2014) 0.99

Preclinical evaluation of the novel, orally bioavailable Selective Inhibitor of Nuclear Export (SINE) KPT-335 in spontaneous canine cancer: results of a phase I study. PLoS One (2014) 0.96

Red Light-Regulated Reversible Nuclear Localization of Proteins in Mammalian Cells and Zebrafish. ACS Synth Biol (2015) 0.94

Manipulation of endogenous kinase activity in living cells using photoswitchable inhibitory peptides. ACS Synth Biol (2014) 0.93

Control of Protein Activity and Cell Fate Specification via Light-Mediated Nuclear Translocation. PLoS One (2015) 0.91

Leptomycin B enhances CDDP-sensitivity via nuclear accumulation of p53 protein in HPV-positive cells. Cancer Sci (2003) 0.87

Roles of the tumor suppressor p53 and the cyclin-dependent kinase inhibitor p21WAF1/CIP1 in receptor-mediated apoptosis of WEHI 231 B lymphoma cells. J Exp Med (1998) 0.84